Stewart Releases Flood Of Discretionary Denial Decisions

By Editorial Team

The acting U.S. Patent and Trademark Office director issued more than a dozen discretionary denial decisions on Thursday and Friday. The decisions largely favored the challenger, highlighting the significant advantage challenges to young patents have. The rulings also included a denial based on assignor estoppel.

Among the decisions released were:

• Charge Fusion Decision
• CleveMed Decision
• Concurrent Decision
• Feit Electric Decision
• Halozyme Decision
• Inari Decision
• Intellectual Ventures Decision
• Natera Decision
• Navy Decision
• Nutanix Decision
• ParTec Decision
• Spinelogik Decision
• Stratasys Decision

The decisions covered a wide range of patent matters, including large dynamic range cameras, application runtime allocation of compute resources, sleep disorder diagnosis and treatment devices, wireless network communication, and more.

Law firms involved in these cases included Altima Advisors Attorneys, Finnegan, Fish & Richardson, Haynes Boone, Perkins Coie, and many others. Companies such as Intel, Microsoft, Tesla, and Merck were among the entities affected by these decisions.

These recent decisions by the U.S. Patent and Trademark Office underscore the importance of staying informed about patent challenges and the evolving landscape of intellectual property law.